Literature DB >> 27981843

Radiolabeled Rhein as Small-Molecule Necrosis Avid Agents for Imaging of Necrotic Myocardium.

Qi Luo1,2,3, Qiaomei Jin2,3, Chang Su1,2,3, Dongjian Zhang2,3, Cuihua Jiang2,3, Anne Folta Fish4, Yuanbo Feng2,3,5, Yicheng Ni2,3,5, Jian Zhang2,3, Zhiqi Yin1.   

Abstract

A rapid and accurate identification of necrotic myocardium is of great importance for diagnosis, risk stratification, clinical decision-making, and prognosis evaluation of myocardial infarction. Here, we explored technetium-99m labeled rhein derivatives for rapid imaging of the necrotic myocardium. Three hydrazinonicotinic acid-linker-rhein (HYNIC-linker-rhein) derivatives were synthesized, and then, these synthetic compounds were labeled with technetium-99m using ethylenediaminediacetic acid (EDDA) and tricine as coligands [99mTc(EDDA)-HYNIC-linker-rhein]. The necrosis avidity of the three 99mTc-labeled rhein derivatives was tested in a mouse model of ethanol-induced muscular necrosis by gamma counting, histochemical staining, and autoradiography. A lead tracer for visualization of necrotic myocardium was assessed by single photon emission computed tomography/computed tomography (SPECT/CT) imaging in a rat model with reperfused myocardial infarction. The necrosis avidity mechanism of the tracer was explored by DNA binding studies in vitro and blocking experiments in vivo. Results showed that the uptake in necrotic muscles of the three 99mTc-compounds was higher than that in viable muscles (P < 0.001). Autoradiography and histochemical staining results were consistent with selective uptake of the radiotracer in the necrotic regions. Among the these tracers, 99mTc(EDDA)-HYNIC-ethylenediamine-rhein [99mTc(EDDA)-HYNIC-2C-rhein] displayed the best distribution profiles for imaging. The necrotic myocardium lesions were clearly visualized by SPECT/CT using 99mTc(EDDA)-HYNIC-2C-rhein at 1 h after injection. The necrotic-to-viable myocardium and necrotic myocardium-to-blood uptake ratios of 99mTc(EDDA)-HYNIC-2C-rhein were 4.79 and 3.02 at 1 h after injection. DNA binding studies suggested HYNIC-linker-rhein bound to DNA through intercalation. The uptake of 99mTc(EDDA)-HYNIC-2C-rhein in necrotic muscle was significantly blocked by excessive unlabeled rhein, with 77.61% decline at 1 h after coinjection. These findings suggested 99mTc(EDDA)-HYNIC-2C-rhein emerged as a "hot spot" imaging probe that has a potential for rapid imaging of necrotic myocardium. The necrosis avidity mechanism of 99mTc(EDDA)-HYNIC-linker-rhein may be due to its interaction with exposed DNA in necrotic tissues.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27981843     DOI: 10.1021/acs.analchem.6b03959

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  6 in total

1.  Target identification and occupancy measurement of necrosis avid agent rhein using bioorthogonal chemistry-enabling probes.

Authors:  Cuihua Jiang; Jian Zhang; Shihe Hu; Meng Gao; Dongjian Zhang; Nan Yao; Qiaomei Jin
Journal:  RSC Adv       Date:  2022-06-06       Impact factor: 4.036

2.  SPECT Imaging of Treatment-Related Tumor Necrosis Using Technetium-99m-Labeled Rhein.

Authors:  Jiajia Liang; Qi Luo; Dongjian Zhang; Qiaomei Jin; Lichao Liu; Wei Liu; Meng Gao; Jian Zhang; Zhiqi Yin
Journal:  Mol Imaging Biol       Date:  2019-08       Impact factor: 3.488

Review 3.  The evolving roles of radiolabeled quinones as small molecular probes in necrotic imaging.

Authors:  Chang Su; Yan Xu
Journal:  Br J Radiol       Date:  2020-05-21       Impact factor: 3.039

4.  Preclinical Evaluation of Radioiodinated Hoechst 33258 for Early Prediction of Tumor Response to Treatment of Vascular-Disrupting Agents.

Authors:  Dongjian Zhang; Meng Gao; Nan Yao; Cuihua Jiang; Wei Liu; Tiannv Li; Shaoli Song; Dejian Huang; Zhiqi Yin; Yunliang Qiu; Qiaomei Jin
Journal:  Contrast Media Mol Imaging       Date:  2018-02-26       Impact factor: 3.161

5.  Updated developments on molecular imaging and therapeutic strategies directed against necrosis.

Authors:  Dongjian Zhang; Meng Gao; Qiaomei Jin; Yicheng Ni; Jian Zhang
Journal:  Acta Pharm Sin B       Date:  2019-02-13       Impact factor: 11.413

6.  In Vivo Evaluation of Gallium-68-Labeled IRDye800CW as a Necrosis Avid Contrast Agent in Solid Tumors.

Authors:  Marcus C M Stroet; Erik de Blois; Joost Haeck; Yann Seimbille; Laura Mezzanotte; Marion de Jong; Clemens W G M Löwik; Kranthi M Panth
Journal:  Contrast Media Mol Imaging       Date:  2021-12-13       Impact factor: 3.161

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.